COO coopercos.com: Forward P/S Multiple

Graphic logo of CooperVision (COO)

Collaboration with reproductive clinics and ophthalmologists requires constant investment, as reflected in the forward price-to-sales valuation trend, where the latest value is recorded as 1.80. Stability is provided by the demand inertia for daily disposable lenses, which serves as a profit generator. This resilience is further bolstered by streamlined international logistics and warehouse automation, ensuring high distribution profitability for The Cooper Companies (COO).

coopercos.com - COO Market Cap to Expected Sales Ratio (period 07/04/2022 - 11/13/2026)

Metric breakdowns and analytics for CooperSurgical (COO)

- current price and projected stock value:
Summary company analytics:CooperCompanies (COO)
Product sample of The Cooper Companies

To determine the fundamental value of The Cooper Companies (COO), an investor must compare market capitalization with projected sales volume. By analyzing the forward price-to-sales valuation chart, one can identify whether the asset is overvalued or possesses growth potential through the ratio of current price to expected revenue. The stability of this multiple is supported by the ownership of high-tech manufacturing plants in the US and Europe, which ensure the predictability of lens supplies.

Key competitors

Forward P/S Multiple BSX (Boston Scientific Corporation)|Edwards (EW) - Market Cap to Future Revenue Ratio|ResMed Corp - Forward P/S Multiple|PODD (Insulet Inc.) - Market Cap to Projected Revenue|ZBH: Forward P/S Multiple|ALGN - Market Cap to Expected Sales Ratio|GMED (Globus Medical) - Forward P/S Multiple|Forward Price-to-Revenue Multiple TransMedics Group Inc (TMDX)|Forward P/S Multiple ATEC|Forward P/S Multiple Artivion Corp (AORT)|Price-to-Projected Revenue Ratio Enovis Corporation ENOV|integralife.com - Price-to-Projected Revenue Ratio|ESTA: Forward Price-to-Revenue Multiple|Forward Price to Sales BBNX (Beta Bionics, Inc.)|IRMD: Forward P/S Multiple|Market Cap to Future Revenue Ratio Embecta Health (EMBC)|Price-to-Projected Revenue Ratio Tandem Diabetes Care|AXGN - Projected Price to Revenue|Forward Price-to-Revenue Multiple SIBN (SI-BONE)|Forward P/S Multiple Orthofix Medical (OFIX)|Forward P/S Multiple BVS (Bioventus Corp)|Market Cap to Expected Sales Ratio OrthoPediatrics Corp (KIDS)|TMCI - Price-to-Projected Revenue Ratio|Future Price to Revenue SRTA|Carlsmed (CARL) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple RxSight Inc|CLPT (ClearPoint Neuro Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Stereotaxis Corporation STXS|Price-to-Projected Revenue Ratio Neuronetics, Inc. (STIM)|sightsciences.com - Market Cap to Projected Revenue|Orchestra BioMed, Inc. - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio ANIK (Anika Therapeutics Inc.)|NSPR: Forward Price-to-Revenue Multiple|Jin Medical International - Price to Expected Revenue Ratio|VANI: Forward P/S Multiple|Xtant Medical - Forward Price to Sales|NMTC (NeuroOne Medical Technologies Corporation) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Modular Med MODD|Forward Price-to-Revenue Multiple MYO (Myomo, Inc)|COCH (Envoy Medical Inc) - Forward Price to Sales|Forward P/S Multiple VVOS (Vivos Therapeutics)|NVNO - Forward Price-to-Revenue Multiple|SINT - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Tenon Medical Inc.|ReWalk Robotics Ltd (LFWD) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Autonomix Medical (AMIX)|Price-to-Projected Revenue Ratio INVO Fertility Inc|bonebiologics.com - Future Price to Revenue|Forward P/S Multiple AXNX|BIOL - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Dynatronics DYNT|Forward Price to Sales FNA|INVO: Forward Price-to-Revenue Multiple